| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| Cxx1b - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN504056 | 1 kit | ORIGENE TECHNOLOGIES |
| Human NmrA-like family domain containing 1 (NMRAL1) from ORIGENE TECHNOLOGIES | TP303602 | 20 ug | ORIGENE TECHNOLOGIES |
| ENC1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN401842 | 1 kit | ORIGENE TECHNOLOGIES |
| Enc1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN505217 | 1 kit | ORIGENE TECHNOLOGIES |
| ENC1 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH301842 | 10 ug | ORIGENE TECHNOLOGIES |
| RSPRY1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN403851 | 1 kit | ORIGENE TECHNOLOGIES |
| Rspry1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN515173 | 1 kit | ORIGENE TECHNOLOGIES |
| TEP1 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN223614 | 1 kit | ORIGENE TECHNOLOGIES |
| TEP1 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN223614LP | 1 kit | ORIGENE TECHNOLOGIES |
| TEP1 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN223614BN | 1 kit | ORIGENE TECHNOLOGIES |
| TEP1 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN223614RB | 1 kit | ORIGENE TECHNOLOGIES |
| Tep1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN517410 | 1 kit | ORIGENE TECHNOLOGIES |
| TEP1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN423614 | 1 kit | ORIGENE TECHNOLOGIES |
| OR6Y1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN420781 | 1 kit | ORIGENE TECHNOLOGIES |
| OR2Y1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN419613 | 1 kit | ORIGENE TECHNOLOGIES |
| Caspase 5, apoptosis-related cysteine peptidase (CASP5), transcript variant a from ORIGENE TECHNOLOGIES | LY401386 | 100 ug | ORIGENE TECHNOLOGIES |
| Caspase 8, apoptosis-related cysteine peptidase (CASP8), transcript variant A from ORIGENE TECHNOLOGIES | LY420061 | 100 ug | ORIGENE TECHNOLOGIES |
| Caspase 3, apoptosis-related cysteine peptidase (CASP3), transcript variant alpha from ORIGENE TECHNOLOGIES | LY418048 | 100 ug | ORIGENE TECHNOLOGIES |
| Caspase 4, apoptosis-related cysteine peptidase (CASP4), transcript variant alpha from ORIGENE TECHNOLOGIES | LY400489 | 100 ug | ORIGENE TECHNOLOGIES |
| Caspase 6, apoptosis-related cysteine peptidase (CASP6), transcript variant alpha from ORIGENE TECHNOLOGIES | LY400490 | 100 ug | ORIGENE TECHNOLOGIES |
| Caspase 7, apoptosis-related cysteine peptidase (CASP7), transcript variant alpha from ORIGENE TECHNOLOGIES | LY420060 | 100 ug | ORIGENE TECHNOLOGIES |
| Caspase 9, apoptosis-related cysteine peptidase (CASP9), transcript variant alpha from ORIGENE TECHNOLOGIES | LY400491 | 100 ug | ORIGENE TECHNOLOGIES |
| Caspase 5, apoptosis-related cysteine peptidase (CASP5), transcript variant b from ORIGENE TECHNOLOGIES | LY427803 | 100 ug | ORIGENE TECHNOLOGIES |
| Caspase 8, apoptosis-related cysteine peptidase (CASP8), transcript variant B from ORIGENE TECHNOLOGIES | LY403245 | 100 ug | ORIGENE TECHNOLOGIES |
| Caspase 3, apoptosis-related cysteine peptidase (CASP3), transcript variant beta from ORIGENE TECHNOLOGIES | LY403215 | 100 ug | ORIGENE TECHNOLOGIES |
| Caspase 7, apoptosis-related cysteine peptidase (CASP7), transcript variant alpha from ORIGENE TECHNOLOGIES | LY429055 | 100 ug | ORIGENE TECHNOLOGIES |
| Caspase 6, apoptosis-related cysteine peptidase (CASP6), transcript variant beta from ORIGENE TECHNOLOGIES | LY409793 | 100 ug | ORIGENE TECHNOLOGIES |
| Caspase 6, apoptosis-related cysteine peptidase (CASP6), transcript variant beta from ORIGENE TECHNOLOGIES | LY429832 | 100 ug | ORIGENE TECHNOLOGIES |
| Caspase 9, apoptosis-related cysteine peptidase (CASP9), transcript variant beta from ORIGENE TECHNOLOGIES | LY409796 | 100 ug | ORIGENE TECHNOLOGIES |
| Caspase 7, apoptosis-related cysteine peptidase (CASP7), transcript variant delta from ORIGENE TECHNOLOGIES | LY409591 | 100 ug | ORIGENE TECHNOLOGIES |
| Caspase 7, apoptosis-related cysteine peptidase (CASP7), transcript variant beta from ORIGENE TECHNOLOGIES | LY409593 | 100 ug | ORIGENE TECHNOLOGIES |
| Caspase 4, apoptosis-related cysteine peptidase (CASP4), transcript variant gamma from ORIGENE TECHNOLOGIES | LY409623 | 100 ug | ORIGENE TECHNOLOGIES |
| Caspase 7, apoptosis-related cysteine peptidase (CASP7), transcript variant gamma from ORIGENE TECHNOLOGIES | LY409592 | 100 ug | ORIGENE TECHNOLOGIES |
| Caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase) (CASP1), transcript variant beta from ORIGENE TECHNOLOGIES | LY429054 | 100 ug | ORIGENE TECHNOLOGIES |
| Caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase) (CASP1), transcript variant beta from ORIGENE TECHNOLOGIES | LY420065 | 100 ug | ORIGENE TECHNOLOGIES |
| Caspase 7, apoptosis-related cysteine peptidase (CASP7), transcript variant delta from ORIGENE TECHNOLOGIES | LY429870 | 100 ug | ORIGENE TECHNOLOGIES |
| Caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase) (CASP1), transcript variant delta from ORIGENE TECHNOLOGIES | LY409613 | 100 ug | ORIGENE TECHNOLOGIES |
| Caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase) (CASP1), transcript variant delta from ORIGENE TECHNOLOGIES | LY429865 | 100 ug | ORIGENE TECHNOLOGIES |
| Caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase) (CASP1), transcript variant gamma from ORIGENE TECHNOLOGIES | LY409612 | 100 ug | ORIGENE TECHNOLOGIES |
| Murine GM-CSF ELISA Kit, 1 x 48-well (pre-coated) from ORIGENE TECHNOLOGIES | EA101699 | 1 x 48-well (pre-coated) | ORIGENE TECHNOLOGIES |
| Murine GM-CSF ELISA Kit, 2 x 96-well (pre-coated) from ORIGENE TECHNOLOGIES | EA101701 | 2 x 96-well (pre-coated) | ORIGENE TECHNOLOGIES |
| Murine GM-CSF ELISA Kit, 1 x 96-well (pre-coated) from ORIGENE TECHNOLOGIES | EA101700 | 1 x 96-well (pre-coated) | ORIGENE TECHNOLOGIES |
| Human cyclin-dependent kinase-like 4 (CDKL4), full length from ORIGENE TECHNOLOGIES | TP760891 | 50 ug | ORIGENE TECHNOLOGIES |
| Human cyclin D-type binding-protein 1 (CCNDBP1), transcript variant 1, full length from ORIGENE TECHNOLOGIES | TP760039 | 50 ug | ORIGENE TECHNOLOGIES |
| Human cyclin D-type binding-protein 1 (CCNDBP1), transcript variant 2, full length from ORIGENE TECHNOLOGIES | TP760964 | 50 ug | ORIGENE TECHNOLOGIES |
| Human cyclin G associated kinase (GAK) from ORIGENE TECHNOLOGIES | TP323572 | 20 ug | ORIGENE TECHNOLOGIES |
| Human cyclin G1 (CCNG1), transcript variant 2, full length from ORIGENE TECHNOLOGIES | TP710281 | 20 ug | ORIGENE TECHNOLOGIES |
| Human cyclin H (CCNH) from ORIGENE TECHNOLOGIES | TP304982 | 20 ug | ORIGENE TECHNOLOGIES |
| Human cyclin I (CCNI) from ORIGENE TECHNOLOGIES | TP301186 | 20 ug | ORIGENE TECHNOLOGIES |
| Human cyclin J-like (CCNJL) from ORIGENE TECHNOLOGIES | TP307852 | 20 ug | ORIGENE TECHNOLOGIES |